One of the largest networks of private medical clinics in Russia — group of companies “Medsi”, which is included in AFK “Sistema” Vladimir Yushenkov, became owners of 12.5% in the developer of artificial intelligence for healthcare “Platform Third opinion”. The company’s products improve the efficiency of monitoring patients with COVID-19, and in the future may allow Medsi to reduce personnel costs.”Meds” became the owner of 12.5% in LLC “Platform a Third opinion” (PTM), which is engaged in the development of services with the use of artificial intelligence technology for health care. This “b” told to “meds”. In particular, the PTM creates products that can recognize abnormal changes on different medical images. In addition, as noted in “meds”, the company has developed services to help improve the efficiency of the routing of patients with suspected COVID-19 for testing, to carry out continuous monitoring of the disease, and to enhance the safety of patients and medical staff in the Department, which is antiviral therapy.According to EGRUL, LLC “Platform a Third opinion” was registered in 2017 and belongs to Anna meshcheriakova (79,2%) and Vadim Konouchine (20%). Still 0,80% Sergey Kachkovsky. In 2019 startup raised 5 million rubles of investments from the savings Bank. The seller shares and other details of the transaction in the “meds” do not open.GK “Medsi” is AFK “System” Vladimir Yevtushenkov and is one of the largest networks of private clinics in Russia. According to its own data, the company has 26 clinics in Moscow and the Moscow region, 18 medical institutions in the regions, as well as medical Wellness center and two resort. The group’s revenue in 2019 was 22.3 billion RUB In “meds” note that the PTM already resterauts products more than 20 medical institutions of Russia. In particular, a monitoring service for patients with COVID-19 is used in the “meds”. The President of group Elena Brusilov indicates that the network has become the first medical company in the country, started to introduce services with artificial intelligence. Without the cooperation with leading medical centers development and testing of the relevant products is impossible, admits Anna Mescheryakova.Now artificial intelligence technology in Russia is not widely developed, says the General Director DSM Group Sergey shuljak. Therefore investments in development projects using artificial intelligence can quickly be recouped, sums up the expert.The deal between “meds” and PTM was the third in the medical market since the beginning of the year. Earlier the Gazprombank became the owner of a minority stake in the popular in the regions network of clinics GK “Expert”, and the structure of the web.Russia VEB Ventures received a share in the company “the Doctor next.”Maria Kotova
